BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11503782)

  • 21. "Rescue" abciximab for complicated percutaneous transluminal coronary angioplasty.
    Garbarz E; Farah B; Vuillemenot A; André F; Angioï M; Machecourt J; Bassand JP; Wolf JE; Danchin N; Prendergast B; Iung B; Vahanian A
    Am J Cardiol; 1998 Sep; 82(6):800-3, A9. PubMed ID: 9761094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of new pharmacologic agents in the treatment of acute thrombotic syndromes.
    Stone GW
    Am J Cardiol; 1999 May; 83(9A):16E-20E. PubMed ID: 10357577
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of unstable angina pectoris. Thrombocyte aggregation inhibition improves chances for survival].
    Z Kardiol; 1998 Aug; 87(8 Suppl Thrombozy):1-3. PubMed ID: 9789356
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost and outcomes analysis of abciximab use in a community teaching hospital.
    Abernathy GB; Hewitt KK
    Am J Health Syst Pharm; 1998 Dec; 55(24 Suppl 4):S35-7. PubMed ID: 9872696
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antithrombotics and interventional cardiology].
    Collet JP; Montalescot G
    Arch Mal Coeur Vaiss; 1999 Nov; 92(11 Suppl):1667-79. PubMed ID: 10598250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unstable angina: integrating new treatments.
    Schulman SP
    Hosp Pract (1995); 1997 Oct; 32(10):139-42, 144, 146-50. PubMed ID: 9341639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiographic findings in patients with refractory unstable angina according to troponin T status.
    Heeschen C; van Den Brand MJ; Hamm CW; Simoons ML
    Circulation; 1999 Oct; 100(14):1509-14. PubMed ID: 10510053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quick resolution with abciximab of giant coronary thrombus].
    Delcán Domínguez JL; García Fernández E; Guerrero Sanz JE
    Rev Esp Cardiol; 2002 May; 55(5):536. PubMed ID: 12015935
    [No Abstract]   [Full Text] [Related]  

  • 29. The CAPTURE trial.
    Umans VA; Kloeg PH; Bronzwaer J
    Lancet; 1997 Aug; 350(9075):445. PubMed ID: 9259679
    [No Abstract]   [Full Text] [Related]  

  • 30. Coronary embolism following aortic and mitral valve replacement: successful management with abciximab and urokinase.
    Quinn EG; Fergusson DJ
    Cathet Cardiovasc Diagn; 1998 Apr; 43(4):457-9. PubMed ID: 9554780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention with thrombocyte aggregation inhibitors in cardiovascular indications].
    Lorenz R
    Internist (Berl); 1989 May; 30(5):315-21. PubMed ID: 2661475
    [No Abstract]   [Full Text] [Related]  

  • 32. [The best of thrombosis in 2002].
    Maillard L
    Arch Mal Coeur Vaiss; 2003 Jan; 96 Spec No 1():61-6. PubMed ID: 12613365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of thrombosis in coronary heart disease.
    de Bono D
    Br Med Bull; 1994 Oct; 50(4):904-10. PubMed ID: 7804737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of abciximab in massive pulmonary embolism with free-floating, intra-cardiac thrombi.
    Kassas S; Cheema AA
    Thromb Haemost; 2004 Oct; 92(4):883-5. PubMed ID: 15499704
    [No Abstract]   [Full Text] [Related]  

  • 35. [Unstable angina pectoris: preventing the infarct. Thrombosis ABC, 14].
    Stiefelhagen P
    MMW Fortschr Med; 2000 Mar; 142(13):36. PubMed ID: 10783622
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mortality in coronary thrombosis].
    Jensen GB
    Ugeskr Laeger; 1998 Mar; 160(10):1449. PubMed ID: 9520610
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial.
    Aguirre FV; Topol EJ; Anderson KM; Kleiman NS; Weisman HF; FitzPatrick SE; Califf RM
    J Invasive Cardiol; 1996; 8 Suppl B():21B-29B. PubMed ID: 10785766
    [No Abstract]   [Full Text] [Related]  

  • 38. [Secondary prevention of myocardial infarct].
    Novo S; Abrignani MG; Strano A
    Cardiologia; 1987 Oct; 32(10):1089-97. PubMed ID: 3319153
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-EffectiveUtilization of Abciximab During Coronary Angioplasty in the Setting of Unstable Angina: A Case Study.
    Muhlestein JB
    J Invasive Cardiol; 1996; 8 Suppl B():48B-50B. PubMed ID: 10785771
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.